Plenary: Prime Time, Sunday

Plenary: Prime Time

Setbacks and Operative Solutions: Robotic Hemorrhage Control

Sunday, May 14
3:30 PM - 4:00 PM
Location: BCEC: Ballroom West

Monish Aron, MD

Presentation(s):

Send Email for Monish Aron

Li-Ming Su, MD

University of Florida College of Medicine

Specialty:
• robotic and laparoscopic surgery
• prostate and kidney cancer, urothelial cancer of the kidney, adrenal tumors

Web page: http://urology.ufl.edu/about-us/faculty-staff-directory/li-ming-su-md/

• Medical Degree: Weil Cornell University Medical College

• Residency: New York Presbyterian Hospital-Cornell University Medical College

• Fellowship: The Johns Hopkins Brady Urological Institute

Dr. Su is the David A. Cofrin Professor and Chairman of the Department of Urology at the University of Florida College of Medicine. He completed his urology residency at the New York Presbyterian Hospital-Weil Cornell Medical College in 2000 and a fellowship in robotics and laparoscopic surgery in 2001 at Johns Hopkins Hospital. He served eight years on faculty at the James Buchanan Brady Urological Institute at Johns Hopkins before coming to the University of Florida in 2008 as the Chief of the Division of Robotic and Minimally Invasive Urologic Surgery. His clinical interests are in minimally invasive surgical therapies including robotic surgery for prostate and kidney cancer. Dr. Su’s research focuses on exploring image-guided surgery for prostate and kidney cancer as well as optical imaging for renal tumors, robotic simulation and virtual reality. He has authored over 90 peer reviewed manuscripts and multiple book chapters including chapters in both Campbell’s Urology and Smith’s Textbook of Endourology. He is the editor of the textbook Atlas of Robotic Urologic Surgery, a surgical atlas that provides step-by-step schematic and video-based instructions and is designed to enhance the learning of novice robotic urologic surgeons. Dr. Su is a member of the American Board of Urology Written Examination Committee and has received national awards including Newsweek’s Top Cancer Doctors (2015) and Castle Connelly’s America’s Top Doctors (2011-2016). Lastly he has received first place audio-visual and manuscript awards for topics of laparoscopic prostate and kidney surgery.

Presentation(s):

Send Email for Li-Ming Su

Erik P. Castle, MD, FACS

Mayo Clinic

Dr. Castle is Professor of Urology at Mayo Clinic College of Medicine. His surgical expertise includes minimally invasive urologic oncology including robot-assisted radical cystectomy, prostatectomy, retroperitoneal lymph node dissection, and partial nephrectomy. He has performed many of these procedures as demonstrations internationally as he pioneered robot cystectomy as well as robot RPLND as the first to develop the approach. He is also the director of the international laparoscopic nephrectomy courses throughout Mexico on behalf of the American Urologic Association and serves on several committees and guidelines panels within the American Urologic Association. He also serves on the Early Detection of Prostate Cancer panel for the National Comprehensive Cancer Network (NCCN).

Dr. Castle's research interests include prostate cancer, bladder cancer and kidney cancer. He is the director of the Desert Mountain CARE Prostate Cancer Research Fund and is the principal investigator of his lab housed at the Mayo Clinic Collaborative Research Building. His basic science research is focused on novel secondary hormonal therapies of prostate cancer and apoptotic pathways related to manipulations of the androgen and estrogen receptors. In addition, genomics of prostate and bladder cancer as well as inflammatory mediators of intravesical therapy of bladder cancer are studied in his lab. He also directs the prospectively collected genitourinary biorepository at Mayo Clinic Arizona that houses over 40,000 specimens.

Presentation(s):

Send Email for Erik Castle

Stephen A. Boorjian, MD

Mayo Clinic

Dr. Stephen A. Boorjian is the Carl Rosen Professor of Urology, Vice Chair of Research for the Department of Urology, and the Director of the Urologic Oncology Fellowship at Mayo Clinic. He received his MD from Harvard Medical School, and was a resident in Urology at New York Presbyterian Hospital-Weill Cornell Medical Center. He subsequently completed a fellowship in Urologic Oncology at Mayo Clinic. Dr. Boorjian has co-authored over 250 manuscripts and book chapters, and was recognized as “Teacher of the Year” in Urology for 2012 by the Mayo Clinic Fellows’ Association. Moreover, he has twice won the Best Reviewer Award and once won the Outstanding Reviewer Award from the Journal of Urology, and has been awarded the Reviewer of the Month as well as Reviewer of the Year by European Urology, where he is now an Associate Editor. He was recognized with the 2014 Young Urologist of the Year award from the AUA and the 2016 Young Investigator Award from the Society of Urologic Oncology. He is a member of the NCCN Guidelines Panels for Bladder Cancer and Penile Cancer, and served on the AUA Non-Muscle Invasive Bladder Cancer Guidelines Panel. His research interests include optimizing the management for patients with high-risk prostate cancer, evaluating the outcomes among patients undergoing radical cystectomy for bladder cancer, and improving surgical therapy for advanced renal cell carcinoma.

Presentation(s):

Send Email for Stephen Boorjian


Assets

Setbacks and Operative Solutions: Robotic Hemorrhage Control



Attendees who have favorited this

Send Email for Setbacks and Operative Solutions: Robotic Hemorrhage Control